Supriya Lifescience Ltd
NSE:SUPRIYA

Watchlist Manager
Supriya Lifescience Ltd Logo
Supriya Lifescience Ltd
NSE:SUPRIYA
Watchlist
Price: 706.75 INR -0.6%
Market Cap: 56.9B INR
Have any thoughts about
Supriya Lifescience Ltd?
Write Note

Supriya Lifescience Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Supriya Lifescience Ltd
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Supriya Lifescience Ltd
NSE:SUPRIYA
Total Receivables
₹2B
CAGR 3-Years
35%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Receivables
₹84.4B
CAGR 3-Years
7%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Receivables
₹55.9B
CAGR 3-Years
17%
CAGR 5-Years
7%
CAGR 10-Years
9%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Receivables
₹129.9B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
10%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Receivables
₹17.9B
CAGR 3-Years
5%
CAGR 5-Years
3%
CAGR 10-Years
3%
M
Mankind Pharma Ltd
NSE:MANKIND
Total Receivables
₹9.4B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Supriya Lifescience Ltd
Glance View

Market Cap
56.9B INR
Industry
Pharmaceuticals

Supriya Lifescience Ltd. supplies active pharmaceuticals ingredients (“APIs”), with a focus on research and development. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2021-12-28. The company focuses on products in various therapeutic segments, such as Anti-Histamine, Anti-Allergics, Vitamins, Anesthetics and Anti-Asthmatics. Its manufacturing facilities include delineated areas for quality check (QC); manufacturing areas with multiple clean rooms; engineering and maintenance; warehouse; materials and finished goods stores; in-house microbiological laboratory, and functional waste treatment plant. The company handles chemical reactions, such as Friedel Craft’s Acylation, Claisen Condensation, Grignard Reaction, Mannich Reaction, Ritter Reaction, Eschweiler Clark reaction, Hydrogenation, Chlorination, Bromination, Decyanation, Isocyanation, Ethoxylation, Nitration, Alkylation, Reduction, Oxidation, Etherification, Chlorosulphonation, Phosphorylation, Chiral resolution, Heterocyclic chemistry, Thermal ring expansion and Protection/Deprotection.

SUPRIYA Intrinsic Value
448.33 INR
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Supriya Lifescience Ltd's Total Receivables?
Total Receivables
2B INR

Based on the financial report for Mar 31, 2024, Supriya Lifescience Ltd's Total Receivables amounts to 2B INR.

What is Supriya Lifescience Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
21%

Over the last year, the Total Receivables growth was 32%. The average annual Total Receivables growth rates for Supriya Lifescience Ltd have been 35% over the past three years , 21% over the past five years .

Back to Top